Abstract P3-03-39: Sentinel lymph node biopsy after surgery with removal of the primary tumor
| العنوان: | Abstract P3-03-39: Sentinel lymph node biopsy after surgery with removal of the primary tumor |
|---|---|
| المؤلفون: | OA Ivanova, Zhil'tsova Ek, Vladimir Semiglazov, SN Novikov, AV Komayachov, PI Krzivickiyi, Nikolaev Ks, GA Dashayan, P. Krivorotko, A. Emelyanov, AA Bessonov, Tengiz Tabagua, K. Zernov, S. Kanaev, LP Gigolaeva |
| المصدر: | Cancer Research. 79:P3-03 |
| بيانات النشر: | American Association for Cancer Research (AACR), 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | Cancer Research, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Sentinel lymph node, Cancer, medicine.disease, Primary tumor, Surgery, Lesion, Breast cancer, Oncology, Biopsy, medicine, Lymph, medicine.symptom, Stage (cooking), business |
| الوصف: | Nowadays, sentinel lymph node biopsy (SLNB) is one of the basic methods for diagnosing the lesion of regional lymph nodes (LN) and it is recommended by experts as a standard method in determining the prevalence of the disease in breast cancer patients (BC). The aim of the study was the possibility of sentinel lymph node biopsy after surgery with removal of the primary tumor. Materials and methods The study was conducted in the N.N. Petrov's National Medical Center of Oncology from 2013 to 2018. SLNB was performed in patients who had a primary tumorectomy in another medical institution. The study included patients with the stage cN0. Radionuclide imaging of the sentinel lymph nodes (SLN) was performed in 37 patients with breast cancer. The injection of radiopharmaceuticals in postoperative scar was performed before the biopsy. Median of the period between the operations was 21 days (14 to 30 days). Results After injection, the image of SLN was obtained in 91.9% (34 of 37) of patients. During the operation, 1-5 sentinel lymph nodes were visualized. The lesion of the sentinel lymph nodes (N+) was detected in 21.6% (8) patients, N0 in 78.4% (29) patients, respectively. There is no data for locoregional relapse for the period of observation from 2014 to nowadays. Conclusions The obtained results are comparable with the results of sentinel lymph node biopsy in primary patients with breast cancer stage cN0. This indicates the possibility of biopsy after surgery with removal of the primary tumor. Citation Format: Zhiltsova E, Krivorotko P, Dashayan G, Emelyanov A, Tabagua T, Bessonov A, Ivanova O, Kanaev S, Novikov S, Krzivickiyi P, Komayachov A, Nikolaev K, Gigolaeva L, Zernov K, Semiglazov V. Sentinel lymph node biopsy after surgery with removal of the primary tumor [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-03-39. |
| تدمد: | 1538-7445 0008-5472 |
| DOI: | 10.1158/1538-7445.sabcs18-p3-03-39 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::bf79d0cd5a021dd4347442685cd1fe93 https://doi.org/10.1158/1538-7445.sabcs18-p3-03-39 |
| رقم الانضمام: | edsair.doi...........bf79d0cd5a021dd4347442685cd1fe93 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15387445 00085472 |
|---|---|
| DOI: | 10.1158/1538-7445.sabcs18-p3-03-39 |